Cargando…

Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer

SIMPLE SUMMARY: Intrinsic or acquired resistance to clinically approved targeted therapies for breast cancer patients is a major cause of treatment failure. Our findings provide conclusive functional evidence that the cell adhesion receptor αvβ3 integrin is a critical mediator of resistance to Human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagpal, Aadya, Needham, Kristen, Lane, Darius J. R., Ayton, Scott, Redvers, Richard P., John, Melissa, Selistre-de-Araujo, Heloisa S., Denoyer, Delphine, Pouliot, Normand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954089/ https://www.ncbi.nlm.nih.gov/pubmed/36831558 http://dx.doi.org/10.3390/cancers15041216

Ejemplares similares

Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis
por: Nagpal, Aadya, et al.
Publicado: (2019)

[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
por: Martin, Ana Carolina B.M., et al.
Publicado: (2017)

Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells
por: Macdonald, Joanna, et al.
Publicado: (2020)

Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
por: Kim, Soo-Hyun, et al.
Publicado: (2018)

The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro
por: Casali, Bruna C., et al.
Publicado: (2022)

Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone
por: Moritz, Milene N.O., et al.
Publicado: (2021)

Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles
por: Altei, Wanessa F., et al.
Publicado: (2020)

Alternative splicing of HER2: a novel mediator of EGFR TKI resistance
por: Yochum, Zachary A., et al.
Publicado: (2020)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan, Jiadi, et al.
Publicado: (2021)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
por: Meedendorp, Arenda D., et al.
Publicado: (2018)

Inhibition of α(v)β(3) integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC)
por: Montenegro, Cyntia F., et al.
Publicado: (2017)

Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis
por: Masaldan, Shashank, et al.
Publicado: (2017)

Recombinant RGD-disintegrin DisBa-01 blocks integrin α(v)β(3) and impairs VEGF signaling in endothelial cells
por: Danilucci, Taís M., et al.
Publicado: (2019)

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
por: Greenough, Mark A., et al.
Publicado: (2022)

TKI safety
por: Hjorth-Hansen, Henrik
Publicado: (2019)

The α6β4 integrin promotes resistance to ferroptosis
por: Brown, Caitlin W., et al.
Publicado: (2017)

Alternagin-C binding to α(2)β(1) integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells
por: Moritz, Milene Nóbrega de Oliveira, et al.
Publicado: (2018)

Tendon Remodeling in Response to Resistance Training, Anabolic Androgenic Steroids and Aging
por: Guzzoni, Vinicius, et al.
Publicado: (2018)

Metastasis inhibition in breast cancer by targeting cancer cell extravasation
por: Cominetti, Márcia R, et al.
Publicado: (2019)

Tumor heterogeneity and the dilemma of antioxidant therapies in cancer
por: Selistre-de-Araujo, Heloisa Sobreiro, et al.
Publicado: (2022)

Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone
por: Sloan, Erica K, et al.
Publicado: (2006)

Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation
por: Blanc-Durand, Félix, et al.
Publicado: (2021)

Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment
por: de Langen, Adrianus J., et al.
Publicado: (2018)

β1A Integrin Is a Master Regulator of Invadosome Organization and Function
por: Destaing, Olivier, et al.
Publicado: (2010)

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
por: Ju, Lixia, et al.
Publicado: (2013)

Mastering Autodesk Inventor 2016 and Autodesk Inventor LT 2016
por: Munford, Paul, et al.
Publicado: (2016)

Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway
por: Sun, Qi, et al.
Publicado: (2022)

The TKI Era in Chronic Leukemias
por: De Novellis, Danilo, et al.
Publicado: (2021)

Laminin-511: A multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis
por: Pouliot, Normand, et al.
Publicado: (2013)

Snake Venom Disintegrins and Cell Migration
por: Selistre-de-Araujo, Heloisa S., et al.
Publicado: (2010)

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant
por: Zhao, Lihao, et al.
Publicado: (2019)

Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca(2+) overload-induced ferroptosis
por: Ni, Yinyun, et al.
Publicado: (2023)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
por: Lei, Jin, et al.
Publicado: (2022)

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer
por: Yin, Zi-Jun, et al.
Publicado: (2018)

Snake Venom Metalloproteinases (SVMPs): A structure-function update
por: Olaoba, Olamide Tosin, et al.
Publicado: (2020)

The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
por: Wang, Chunyu, et al.
Publicado: (2019)

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer
por: Park, Soon Young, et al.
Publicado: (2023)

Growth effect of tki treatment in childhood CML
por: Jeon, Yeon Jin, et al.
Publicado: (2015)

Synergistic SNGI-TKI combination against LSCs
por: Jiang, Xiaoyan
Publicado: (2017)

Management of VEGFR-Targeted TKI for Thyroid Cancer
por: Enokida, Tomohiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61a3qb2trv3c1m8h782qdc1uek